These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14472804)

  • 41. [ON SEMEIOLOGIC AND PHYSIOPATHOLOGIC SIGNIFICANCE OF TESTS OF HEPARIN STIMULATION OF THE CLEARING FACTOR IN ATHEROSCLEROSIS].
    STRATA A; CUCURACHI L; SALVATORE V; CASTELLO S
    G Clin Med; 1963 Jun; 44():545-61. PubMed ID: 14325395
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of nicotinic acid on blood coagulation, blood heparin content and clearing factor in patients with atherosclerosis].
    GERASIMOVA IL
    Kardiologiia; 1963; 3():61-4. PubMed ID: 13947300
    [No Abstract]   [Full Text] [Related]  

  • 43. [Total mesenteric infarct caused by thrombosis of the mesenteric vein; cure with anti-coagulant therapy].
    DE THOMASSON
    Mem Acad Chir (Paris); 1956 Oct 7-Nov 31; 82(27-28):843-5. PubMed ID: 13386922
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experimental cholesterin atherosclerosis in the rabbit: action of a duodenal heparinoid. III. Modifications in the factors of hemocoagulation, plasmin and plasminogen, and in the thromboplastin and fibrinolytic activity of the aortic wall].
    SOARDI F; NICROSINI F; DEL FAVERO A; PASOTTI C
    Farmaco Prat; 1961 Nov; 16():560-8. PubMed ID: 14039393
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anticoagulants in the treatment of atherosclerosis].
    RAYNAUD R; D'ESHOUGUES JR; NAKACHE G
    Presse Med (1893); 1955 Nov; 63(77):1594-5. PubMed ID: 13289603
    [No Abstract]   [Full Text] [Related]  

  • 46. [On the clearing action of a heparin-trypsin compound].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1962 Jan; 38():1-2. PubMed ID: 13875919
    [No Abstract]   [Full Text] [Related]  

  • 47. [Brief comments on the treatment of atherosclerosis with a hypolipid diet].
    GARRETT A
    Port Med; 1952 Jul; 36(7):343-52. PubMed ID: 13026587
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the long-term heparin treatment of arteriosclerosis and esential hyperlipemia].
    HEYMANN W
    Internist (Berl); 1961 Mar; 2():140-54. PubMed ID: 13714075
    [No Abstract]   [Full Text] [Related]  

  • 49. Chelation therapy in atherosclerosis.
    OLWIN JH; KOPPEL JL
    Ill Med J; 1962 Sep; 122():292-4. PubMed ID: 14481976
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of diethylstilbestrol in atherosclerosis].
    MIASNIKOV LA
    Sov Med; 1961 Nov; 25():90-5. PubMed ID: 14473297
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of atherosclerosis by diet. I. Results in patients followed from 36 to 72 months.
    NELSON AM
    Northwest Med; 1956 Jun; 55(6):643-9. PubMed ID: 13322315
    [No Abstract]   [Full Text] [Related]  

  • 52. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of chronic injection of a heparin complex on aortic atherosclerosis in cholesterol-fed chickens.
    OPDYKE DF; ROSENBERG A; SILBER R; OTT WH; SIEGEL H
    J Lab Clin Med; 1955 Feb; 45(2):270-3. PubMed ID: 13233654
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of heparin on cholesterol partition, lipoproteins and atherosclerosis in experimental hypercholesterolemia.
    MOSES C; RHODES GL
    Angiology; 1954 Oct; 5(5):429-32. PubMed ID: 13197814
    [No Abstract]   [Full Text] [Related]  

  • 55. Atherosclerosis and dextrorotatory thyroxine.
    SD J Med Pharm; 1961 May; 14():204-11. PubMed ID: 14447393
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapy of atherosclerosis with oils and phosphatides].
    KRICKAU G
    Med Monatsschr; 1962 Feb; 16():80-4. PubMed ID: 14459643
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of atherosclerosis by diet. III. Selection and management of patients.
    NELSON AM
    Northwest Med; 1956 Aug; 55(8):874-8. PubMed ID: 13348983
    [No Abstract]   [Full Text] [Related]  

  • 58. [Atherosclerosis and experimental treatment with lipotropic substances combined with a polysorbe 80].
    LAURENDEAU E; DENIS M
    Union Med Can; 1954 Oct; 83(10):1092-100. PubMed ID: 13226526
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of heparin on development of atherosclerosis and fatty liver; a report of studies on cholesterol-fed rabbits.
    MENG HC; DAVIS WS
    AMA Arch Pathol; 1955 Sep; 60(3):276-80. PubMed ID: 13248338
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experiences with the administration of heparin in patients with cerebral arteriosclerosis].
    KECOVA H
    Cas Lek Cesk; 1957 Feb; 96(7):193-8. PubMed ID: 13413918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.